http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. Fanconi anemia is a recessive genetic disorder affecting 1 in 350,000 babies, which leaves cells unable to repair damaged DNA. This lack of repair puts Fanconi anemia patients at high risk for developing a variety of cancers, especially leukemias and head and neck cancer. Cruelly, the condition also nixes the use of an entire class of cancer drugs, namely drugs like mitomycin C that act by encouraging DNA to crosslink together like sticky strands of bread dough – generally, healthy cells can repair a few crosslinks whereas cancer cells cannot and so are killed. However, Fanconi anemia patients are unable to repair the damage done to healthy or cancerous cells done by these drugs and so treatment with mitomycin C is frequently fatal. http://medicalxpress.com/news/2012-09-rare-genetic-disease-insight-common.html Cancer Tue, 04 Sep 2012 17:18:52 EST news265997925 (HealthDay) -- The addition of two well-tolerated chemotherapy drugs to radiation therapy led to significantly longer survival rates among patients with muscle-invasive bladder cancer. http://medicalxpress.com/news/2012-04-chemo-bladder-cancer.html Cancer Thu, 19 Apr 2012 03:12:48 EST news254023957